REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 115 filers reported holding REVANCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,655 | +0.8% | 18,976 | +122.5% | 0.00% | 0.0% |
| Q2 2023 | $215,894 | -18.2% | 8,530 | -49.1% | 0.00% | 0.0% |
| Q1 2019 | $264,000 | -70.3% | 16,759 | -62.0% | 0.00% | -83.3% |
| Q4 2018 | $888,000 | -19.9% | 44,090 | -1.2% | 0.01% | 0.0% |
| Q3 2018 | $1,109,000 | -5.9% | 44,610 | +4.0% | 0.01% | -14.3% |
| Q2 2018 | $1,178,000 | – | 42,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |